| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.006 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.006 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.006 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.085 | 0.007 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.007 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.076 | 0.007 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.079 | 0.007 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.008 |